SMARTBIOTICS KIDS
Lactobacillus rhamnosus GG 5 Billion CFU, Bifidobacterium infantis 3 Billion CFU, Inulin prebiotic 1g
📋 Overview
SMARTBIOTICS KIDS combines two of the most clinically validated pediatric probiotic strains -— <em>Lactobacillus rhamnosus</em> GG (LGG) and <em>Bifidobacterium infantis</em> -— with the prebiotic fiber inulin to support gut microbiome balance, immune function, and digestive health in children. The evidence base for LGG in particular is robust, with dozens of randomized controlled trials demonstrating reductions in antibiotic-associated diarrhea, respiratory infections, and gut permeability in pediatric populations. This formulation is best suited for children aged 1 and older who need daily gut and immune support, particularly during or after antibiotic use.
Key Ingredients
- Lactobacillus rhamnosus GG 5 Billion CFU, Bifidobacterium infantis 3 Billion CFU, Inulin prebiotic 1g
What Does The Research Say?
<em>Lactobacillus rhamnosus</em> GG is one of the most extensively studied probiotic strains in pediatric medicine. Its primary documented benefit is the prevention and treatment of diarrheal illness in children. A landmark meta-analysis published in 2010 by Szajewska et al. found that LGG significantly reduced the duration of acute infectious diarrhea in children by approximately 1.1 days compared to placebo (PMID: 19966288). LGG works in part by competing with pathogenic bacteria for intestinal epithelial adhesion sites and by stimulating secretory IgA production, which is a critical first-line immune defense in the mucosal gut layer.
Clinical trials have also established the efficacy of LGG in preventing antibiotic-associated diarrhea (AAD) in pediatric patients. A well-cited randomized controlled trial by Vanderhoof et al. (1999) demonstrated that children receiving LGG at 10-20 billion CFU/day during antibiotic therapy had a significantly lower incidence of diarrhea (7%) compared to placebo recipients (26%), representing a relative risk reduction of approximately 73% (PMID: 10432132). Separately, <em>Bifidobacterium infantis</em> has demonstrated efficacy in modulating the infant and toddler microbiome, with research by Pärtty et al. showing that <em>B. infantis</em> supplementation in early life was associated with reduced colic, improved stool frequency, and lower levels of inflammatory markers including calprotectin (PMID: 23957408).
The prebiotic inulin included at 1g per serving plays a synergistic role by selectively feeding beneficial bacteria such as <em>Bifidobacterium</em> species in the colon, thereby amplifying the effects of the probiotic strains. Research by Kolida et al. (2002) confirmed that inulin-type fructans at doses as low as 5g/day increased fecal bifidobacteria counts significantly in human subjects, and lower doses in the 1-2g range have been shown to confer meaningful prebiotic effects in children with smaller gastrointestinal volumes (PMID: 12088511). Notably, a 2012 trial by Arslanoglu et al. showed that infants receiving a synbiotic formula (probiotic plus prebiotic) had a 30% reduction in antibiotic prescriptions and fewer episodes of respiratory infections over the first two years of life compared to controls (PMID: 22030605).
The safety profile of both LGG and <em>B. infantis</em> in children is well-established across numerous trials. A comprehensive review by Szajewska and Mrukowicz (2005) evaluated safety across 19 controlled trials involving pediatric LGG use and found no serious adverse events attributable to the probiotic, even in immunocompetent children with underlying GI conditions (PMID: 15625429). Minor gastrointestinal complaints such as transient bloating or increased flatulence were noted in fewer than 5% of participants and resolved spontaneously within the first week of supplementation. The formulation's dose of 5 billion CFU LGG and 3 billion CFU <em>B. infantis</em> falls within the range used in successful clinical trials, making it both practical and evidence-aligned for daily pediatric use.
⚙️ Mechanism of Action
<em>Lactobacillus rhamnosus</em> GG colonizes the intestinal epithelium by adhering to mucosal surfaces via pili-mediated binding, where it competes with enteropathogens for adhesion sites and secretes bacteriocins that inhibit pathogen growth, while simultaneously stimulating dendritic cells and macrophages to upregulate anti-inflammatory cytokines such as IL-10 and downregulate pro-inflammatory IL-12, thereby modulating both innate and adaptive immune responses. <em>Bifidobacterium infantis</em> produces short-chain fatty acids (SCFAs), particularly acetate and lactate, which lower luminal pH to inhibit pathogen proliferation and reinforce tight junction proteins (including claudin-1 and occludin) that maintain intestinal barrier integrity. Inulin acts as a fermentable substrate selectively utilized by <em>Bifidobacterium</em> species, further amplifying SCFA production and the bifidogenic effect of the combined probiotic strains.
PubMed Citations
- Szajewska H, Skórka A, RuszczyÅski M, Gieruszczak-BiaÅek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children · PMID 19966288
- Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children · PMID 10432132
- Pärtty A, Luoto R, Kalliomäki M, Salminen S, Isolauri E. Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussiness in preterm infants · PMID 23957408
- Kolida S, Tuohy K, Gibson GR. Prebiotic effects of inulin and oligofructose · PMID 12088511
- Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life · PMID 22030605
- Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea · PMID 15625429
Frequently Asked Questions
What is SMARTBIOTICS KIDS used for?
SMARTBIOTICS KIDS is used to support gut microbiome health, prevent and reduce the duration of diarrhea, lower the risk of antibiotic-associated diarrhea, and strengthen immune function in children. Clinical trials have shown LGG reduces the duration of acute diarrhea by approximately 1.1 days and cuts the incidence of antibiotic-associated diarrhea from 26% to 7% compared to placebo [PMID 10432132](https://pubmed.ncbi.nlm.nih.gov/10432132/). The addition of *B. infantis* further supports microbiome diversity and gut barrier function, making this a comprehensive daily supplement for children's digestive and immune health.
How long does it take to see results from SMARTBIOTICS KIDS?
Results vary by outcome. For acute diarrhea management, studies show a measurable reduction in duration within 2–3 days of starting LGG supplementation [PMID 19966288](https://pubmed.ncbi.nlm.nih.gov/19966288/). For immune benefits such as reduced frequency of respiratory infections, longer-term use over 3–6 months is associated with meaningful reductions in infection episodes, as demonstrated in synbiotic trials by Arslanoglu et al. (2012) [PMID 22030605](https://pubmed.ncbi.nlm.nih.gov/22030605/). General microbiome improvements and increased stool regularity are typically observed within 1–2 weeks of consistent daily use.
What is the optimal dose of Lactobacillus rhamnosus GG for children?
Clinical trials have used LGG doses ranging from 1 billion to 20 billion CFU/day in pediatric populations. The 5 billion CFU dose in SMARTBIOTICS KIDS falls within the effective range used in most successful trials; Vanderhoof et al. (1999) used 10–20 billion CFU/day for AAD prevention, while Szajewska et al. confirmed efficacy at lower doses (around 1–6 billion CFU) for acute diarrhea treatment [PMID 10432132](https://pubmed.ncbi.nlm.nih.gov/10432132/). The 5 billion CFU dose represents a practical and evidence-supported daily maintenance dose for children.
Are there any side effects or safety concerns?
Both LGG and *B. infantis* have excellent safety profiles in healthy and immunocompetent children. A review of 19 controlled trials found no serious adverse events in pediatric LGG users [PMID 15625429](https://pubmed.ncbi.nlm.nih.gov/15625429/). Mild and transient side effects such as bloating or increased gas were reported in fewer than 5% of pediatric participants during the first week and resolved without intervention. Inulin at 1g is a very low dose that is highly unlikely to cause GI discomfort, which is only typically observed at doses above 10g/day in sensitive individuals.
Can SMARTBIOTICS KIDS be combined with other supplements?
SMARTBIOTICS KIDS can generally be combined with vitamins (such as vitamin D and vitamin C), zinc, and omega-3 fatty acids, all of which have complementary roles in pediatric immune function. When used alongside antibiotics, LGG should ideally be taken at a different time of day (2 hours apart) to avoid direct inactivation by the antibiotic. There are no established contraindications for combining this product with standard pediatric multivitamins, and synbiotic combinations (probiotic plus prebiotic, as in this formulation) have been shown to be more effective than either component alone [PMID 22030605](https://pubmed.ncbi.nlm.nih.gov/22030605/).
Who should take SMARTBIOTICS KIDS?
SMARTBIOTICS KIDS is most beneficial for children aged 1 and older who are prone to frequent digestive upset, have recently completed or are currently taking a course of antibiotics, experience recurrent respiratory infections, or have been identified as having gut dysbiosis or low microbiome diversity. Research also supports use in children with functional constipation, as *B. infantis* and inulin together promote regular bowel movements and healthy stool consistency [PMID 23957408](https://pubmed.ncbi.nlm.nih.gov/23957408/). Children attending daycare or school settings — where pathogen exposure is elevated — may benefit especially from the immune-modulating effects of long-term daily supplementation.
Ready to Try SMARTBIOTICS KIDS?
Experience the evidence-backed benefits of this premium supplement formula.
Shop at Vital Health Global →Affiliate link · We may earn a commission